HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Absence of the Gly40-ser mutation in the glucagon receptor gene in Japanese subjects with NIDDM.

Abstract
Recent studies have shown both association and linkage between a Gly40-Ser mutation in the glucagon receptor gene and NIDDM in French patients with familial NIDDM. This mutation was present in heterozygous form in 4.6% of diabetic probands but only 1% of the French population, suggesting that it was an important risk factor in the development of NIDDM. A total of 348 unrelated Japanese subjects (220 with NIDDM, 53 with impaired glucose tolerance (IGT) and 75 normal subjects) were screened for the presence of the Gly40-Ser mutation. Seventy-two percent of the NIDDM patients and 52% of IGT subjects had a positive family history of NIDDM. The Gly40-Ser mutation, which could be readily detected in a positive control subject, was not found in any of the 348 Japanese subjects studied. Thus, the Gly40-Ser mutation does not play an important role in the pathogenesis of NIDDM in Japanese patients.
AuthorsM Ogata, N Iwasaki, H Ohgawara, S Karibe, Y Omori
JournalDiabetes research and clinical practice (Diabetes Res Clin Pract) Vol. 33 Issue 2 Pg. 71-4 (Jul 1996) ISSN: 0168-8227 [Print] Ireland
PMID8879960 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Glucagon
Topics
  • Adult
  • Aged
  • Asian People (genetics)
  • Autoradiography
  • Diabetes Mellitus, Type 2 (epidemiology, genetics, physiopathology)
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Gene Frequency
  • Glucose Intolerance (epidemiology, genetics)
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Mutation (genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Receptors, Glucagon (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: